poisar

Stocks · News reference

JP Morgan Maintains Overweight on Olema Pharmaceuticals, Lowers Price Target to $46

Aug 13, 2026, 3:28 PMBenzinga Newsdesk

JP Morgan analyst Anupam Rama maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Overweight and lowers the price target from $52 to $46.

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

OLMA
Source
benzinga
Observed
Aug 13, 2026, 3:28 PM
Checked
Aug 13, 2026, 3:28 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Aug 13, 2026, 11:05 AMSEC EDGAR

    8-K filing — Olema Pharmaceuticals, Inc. (OLMA)

    Filed: 2026-08-13 AccNo: 0001193125-26-347853 Size: 593 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

    Read original at edgar
    OLMA